Author:
Shoji Takuhiro,Kanamori Masayuki,Inoue Jun,Saito Ryuta,Osada Yoshinari,Shimoda Yoshiteru,Chonan Masashi,Uenohara Hiroshi,Masamune Atsushi,Tominaga Teiji
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference42 articles.
1. European Association for the Study of the Liver (2017) EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 67:370–398. https://doi.org/10.1016/j.jhep.2017.03.021
2. Sagnelli C, Pisaturo M, Calò F et al (2019) Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World J Gastroenterol 25:3299–3312. https://doi.org/10.3748/wjg.v25.i26.3299
3. Cholongitas E, Haidich AB, Apostolidou-Kiouti F et al (2018) Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review. Ann Gastroenterol 31:480–490
4. Dong HJ, Ni LN, Sheng GF et al (2013) Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a metaanalysis. J Clin Virol 57:209–214. https://doi.org/10.1016/j.jcv.2013.03.010
5. Evens AM, Jovanovic BD, Su YC et al (2011) Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol 22:1170–1180. https://doi.org/10.1093/annonc/mdq583
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献